3Er-Yuan Liao,Xian-Ping Wu,Xiang-Hang Luo.Establishment and evaluation of bone mineral density reference databases appropriate for diagnosis and evaluation of osteoporosis in Chinese women[J].Journal of Bone & Mineral Metabolism; 2003,21(3),184.
4Kelly PJ,Pocock NA,Sambrook PN,etal.Age and menopause -related changes in indices of bone turnover[J].Clin Endocrinol Metab,1989,69 (6),1160-1165.
5Mazzuoli GF,Diacinti D,Acea M,et al.Relationship between spine bone mineral density and vertebral body heights[J].Calcif Tissue int,1998,62:486-490.
6杜长慧.广义线性模型在新药临床试验中的应用[D].成都四川大学,2003.
7Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative randomized controlled trial.JAMA,2002,288 (3):321-333.
8Lindsay R,Gallagher JC,Kleerekoper M,et al.Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in acetate on bone in early postmenopausal women.JAMA,2002,287 (20):2668-2676.
9Delmas PD,Confavreux E,Garnero P,et al.A combination of low doses of 17β-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women.Osteoporosis Int,2000,11 (2):177-187.
10Lees B,Stevenson JC.The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol17 beta and dydrogesterone.Osteopotos Int,2001,12 (4):251-258.
